HEATHROW, FL--(Marketwire - January 08, 2008) - The CEO and President of IDenta Corp. (PINKSHEETS: IDTA) said in a letter to shareholders today that the company expects to garner significant market share of the U.S. on-site drug detection marketplace during 2008. The forecast is based on sales reports and product orders from Jant Pharmacal, www.accutest.net, IDenta’s primary U.S. marketing partner.
